[
  {
    "id": 41,
    "question": "Scenario for patient developed embolic stroke, his routine work up unremarkable, what to do next?",
    "option_a": "",
    "option_b": "is assumed to represent the choice of extended cardiac monitoring. This is the correct next step after a negative initial evaluation in a patient with an embolic stroke pattern.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nEmbolic strokes occur when a clot formed elsewhere, most commonly in the heart, dislodges and travels to the cerebral circulation. When routine etiological work\u2010up (e.g., basic transthoracic echocardiography, carotid ultrasound) is unremarkable, the stroke remains cryptogenic or classified as an Embolic Stroke of Undetermined Source (ESUS).\n\n**Pathophysiology**\n\nIn many cryptogenic strokes, paroxysmal atrial fibrillation is suspected even though it can be missed on a standard workup. Clots form in the left atrium or appendage due to stasis, and intermittent arrhythmia leads to embolization. Up\u2010to\u2010date evidence, including studies such as the CRYSTAL\u2010AF trial, supports that prolonged cardiac monitoring increases detection of intermittent arrhythmias as the inciting cause.\n\n**Clinical Correlation**\n\nPatients with embolic strokes typically present with sudden focal neurological deficits. In cases where the conventional workup proves negative, the clinical suspicion for paroxysmal atrial fibrillation remains high, and this may be the hidden source of embolism.\n\n**Diagnostic Approach**\n\nAfter initial neuroimaging (CT/MRI) and cardiac evaluation with TTE/TEE have ruled out obvious sources, the next diagnostic step is long-term cardiac monitoring. Differential diagnoses include other embolic sources (e.g., aortic arch atheroma), small vessel lacunar strokes, or non-embolic etiologies; however, the multifocal embolic pattern generally steers workup toward paroxysmal arrhythmias.\n\n**Management Principles**\n\nFirst-line management after a negative routine workup is to utilize prolonged cardiac rhythm monitoring (e.g., a 30-day event monitor or even an implantable loop recorder if indicated) to detect paroxysmal atrial fibrillation. If AF is detected, long-term anticoagulation is recommended. In pregnant or lactating patients, if anticoagulation becomes necessary, unfractionated heparin or low molecular weight heparin (LMWH) is preferred due to their safety profiles during pregnancy and lactation.\n\n**Option Analysis**\n\nAlthough the specific answer choices aren\u2019t provided, answer option B is assumed to represent the choice of extended cardiac monitoring. This is the correct next step after a negative initial evaluation in a patient with an embolic stroke pattern.\n\n**Clinical Pearls**\n\n1. Cryptogenic strokes account for a significant proportion of embolic strokes where routine testing is negative. 2. Prolonged cardiac monitoring increases the diagnostic yield for detecting paroxysmal atrial fibrillation. 3. Once AF is documented, the management pivots to anticoagulation rather than antiplatelet therapy.\n\n**Current Evidence**\n\nRecent trials like CRYSTAL\u2010AF and EMBRACE have solidified the role of prolonged cardiac monitoring in detecting paroxysmal atrial fibrillation in patients with cryptogenic stroke, influencing recent guideline recommendations from the American Stroke Association.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "id": 42,
    "question": "Scenario for ischemic stroke, imaging showed bilateral anterior and posterior circulation strokes, what is the best step for management of this patient if TTE and TEE were negative?",
    "option_a": "",
    "option_b": ", which is presumed to represent the strategy of prolonged or extended cardiac monitoring, is correct. It targets the possibility of intermittent atrial fibrillation that may have been missed on initial examinations.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nWhen imaging demonstrates strokes in both the anterior and posterior circulation bilaterally, a cardioembolic source is highly suspected. Even if initial cardiac studies (TTE and TEE) are negative, intermittent or paroxysmal atrial fibrillation may still be the underlying cause.\n\n**Pathophysiology**\n\nThe mechanism behind such multi-territorial strokes is most often embolic in nature. Paroxysmal atrial fibrillation can be elusive because its episodes may be transient. Negative echocardiographic studies do not rule out arrhythmogenic causes, hence the importance of prolonged rhythm monitoring.\n\n**Clinical Correlation**\n\nPatients with multi-territorial infarctions can present with a combination of neurological deficits affecting different regions. The finding of strokes in multiple vascular territories strongly suggests an embolic source even in the absence of structural abnormalities on TTE/TEE.\n\n**Diagnostic Approach**\n\nAfter ruling out major cardiac sources with TTE and TEE, it is important to pursue extended monitoring, such as with Holter monitors or implantable loop recorders, to detect intermittent arrhythmias like atrial fibrillation. Differential considerations include aortic arch atheroma, hypercoagulable states, or less common embolic sources, but the clinical pattern directs the workup toward paroxysmal AF.\n\n**Management Principles**\n\nIn light of a negative TTE/TEE and a high clinical suspicion for paroxysmal atrial fibrillation, the first-line management is prolonged cardiac rhythm monitoring. If atrial fibrillation is subsequently detected, then the patient should be managed with anticoagulation rather than antiplatelet therapy. In pregnant or lactating patients, LMWH is currently preferred for anticoagulation due to its safety profile.\n\n**Option Analysis**\n\nOption B, which is presumed to represent the strategy of prolonged or extended cardiac monitoring, is correct. It targets the possibility of intermittent atrial fibrillation that may have been missed on initial examinations.\n\n**Clinical Pearls**\n\n1. Bilateral and multi-territorial strokes strongly raise the suspicion of a cardioembolic source. 2. Negative initial echocardiograms do not exclude paroxysmal atrial fibrillation. 3. Prolonged cardiac monitoring can reveal intermittent arrhythmias that guide appropriate anticoagulation therapy.\n\n**Current Evidence**\n\nRecent studies and guideline updates emphasize the diagnostic utility of prolonged cardiac monitoring (e.g., via the EMBRACE or CRYSTAL-AF trials) in evaluating patients with ESUS, reinforcing this strategy in clinical practice.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "id": 43,
    "question": "Picture of spine MRI for patient has progressive myelopathy, ask about the diagnosis",
    "option_a": "",
    "option_b": "corresponds to 'cervical spondylotic myelopathy', this is the correct choice based on the clinical picture and typical MRI findings associated with the condition.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nProgressive myelopathy refers to a slowly worsening dysfunction of the spinal cord. In older adults, one of the most common causes is degenerative changes in the cervical spine, commonly known as cervical spondylotic myelopathy.\n\n**Pathophysiology**\n\nCervical spondylotic myelopathy is caused by chronic degenerative changes such as disc herniation, osteophyte formation, ligamentum flavum hypertrophy, and sometimes ossification of the posterior longitudinal ligament. These changes lead to narrowing of the spinal canal (stenosis) and subsequent compression of the spinal cord.\n\n**Clinical Correlation**\n\nPatients typically present with gradual onset of motor weakness, gait instability, sensory disturbances, and in some cases, hyperreflexia. The progression is usually insidious, reflecting the slow nature of degenerative changes in the cervical spine.\n\n**Diagnostic Approach**\n\nDiagnosis is established with magnetic resonance imaging (MRI) of the spine, which reveals features such as spinal canal narrowing and intramedullary hyperintensities indicative of cord compression. Differential diagnoses include demyelinating diseases (e.g., multiple sclerosis), intramedullary tumors, infectious processes (e.g., spinal epidural abscess), and inflammatory conditions. Correlation with clinical findings is essential.\n\n**Management Principles**\n\nThe first-line management often involves conservative treatment (physical therapy, pain management, and careful monitoring) in mild cases. However, in individuals with progressive neurological deficits, surgical decompression (e.g., anterior cervical discectomy and fusion or laminectomy) is recommended. For pregnant or lactating patients, the treatment approach must carefully weigh the risks and benefits; conservative management is preferred if the deficits are not severe, but if surgery is necessary, timing and anesthetic considerations become critical.\n\n**Option Analysis**\n\nAssuming option B corresponds to 'cervical spondylotic myelopathy', this is the correct choice based on the clinical picture and typical MRI findings associated with the condition.\n\n**Clinical Pearls**\n\n1. Cervical spondylotic myelopathy is a common cause of progressive spinal cord compression in elderly patients. 2. MRI is the diagnostic modality of choice to evaluate for cord compression. 3. Early surgical intervention in progressive cases can improve neurological outcomes.\n\n**Current Evidence**\n\nRecent guidelines suggest that early surgical decompression in patients with moderate to severe deficits can lead to improved long-term outcomes. Ongoing research continues to refine the indications and timing for surgery based on imaging and clinical severity.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "id": 44,
    "question": "Acute stroke With CT image with no established stroke ASPECT 8? Was treated with tPA CTA done and prepared for thrombectomy then he vomited and become lethargic bp 180/110",
    "option_a": "decrease bp",
    "option_b": "Stop tPA",
    "option_c": "Send him to CT",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAcute ischemic stroke treatment often includes intravenous thrombolysis (tPA) and, when indicated, endovascular thrombectomy. However, post-treatment complications must be vigilantly monitored.\n\n**Pathophysiology**\n\ntPA increases the risk of hemorrhagic transformation, especially in the setting of large infarct volumes or uncontrolled hypertension. A sudden deterioration, such as vomiting and lethargy, may signal an intracranial hemorrhage or increased intracranial pressure secondary to bleeding, particularly if blood pressure rises to levels like 180/110 mm Hg.\n\n**Clinical Correlation**\n\nIn this scenario, the patient initially had a favorable CT (ASPECTS 8) and was being managed with tPA while being evaluated for thrombectomy. The subsequent acute neurological deterioration (vomiting, lethargy) in the context of elevated blood pressure is highly concerning for a hemorrhagic complication or neurologic worsening, warranting immediate re-evaluation.\n\n**Diagnostic Approach**\n\nThe first step in managing sudden neurological decline after thrombolysis is to rapidly re-image the brain using non-contrast CT to assess for hemorrhagic transformation. Differential diagnoses include hemorrhagic transformation of the infarct, malignant cerebral edema, or even an unrelated complication. Immediate imaging helps differentiate these conditions.\n\n**Management Principles**\n\nAccording to current stroke guidelines, the initial management for any suspected hemorrhagic complication post tPA is to obtain emergent neuroimaging to confirm the diagnosis. Blood pressure management is also critical; while strict BP control (generally <185/110 mm Hg pre-tPA) is maintained during and after thrombolysis, any new neurological changes necessitate re-imaging before further interventions. In pregnant or lactating patients, imaging protocols remain the same, and care should be taken in selecting antihypertensive agents that are safe in these populations (e.g., labetalol or hydralazine).\n\n**Option Analysis**\n\nOption C, which directs the clinician to send the patient for an immediate CT scan, is the appropriate response. Options such as just decreasing blood pressure or stopping tPA are premature without confirming hemorrhage via re-imaging. The CT scan is needed to determine the correct next steps.\n\n**Clinical Pearls**\n\n1. Any sudden neurological change during or after thrombolytic therapy should prompt immediate re-imaging. 2. Elevated blood pressure post-tPA, especially in the setting of neurological deterioration, raises concern for hemorrhage. 3. Adhering to BP thresholds during thrombolytic therapy is crucial to minimize hemorrhagic risk.\n\n**Current Evidence**\n\nCurrent guidelines from the American Heart Association/American Stroke Association continue to stress the importance of urgent non-contrast head CT in the assessment of suspected hemorrhagic complications after tPA administration. Recent studies emphasize the predictive value of re-imaging when patients show clinical deterioration.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 45,
    "question": "Case of press female with high BP 180/?? Presented with seizure and confusion with MRI showing bilateral occipital cortical hyperintensity dx",
    "option_a": "PRESS",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis case describes a hypertensive female presenting with seizures and confusion, with MRI findings of bilateral occipital cortical hyperintensities. The clinical picture is characteristic of Posterior Reversible Encephalopathy Syndrome (PRES), a clinical\u2013radiological entity often seen in the setting of severe hypertension (and other triggers such as eclampsia, renal failure, or immunosuppressive therapy).\n\n**Pathophysiology**\n\nPRES is believed to result from a failure of autoregulation in the cerebral vasculature caused primarily by sudden severe hypertension. This leads to endothelial dysfunction and subsequent vasogenic edema (predominantly in the posterior circulation\u2014in the parieto\u2010occipital regions). Recent research supports the idea that cerebral hyperperfusion and disruption of the blood\u2013brain barrier are key mechanisms in its development.\n\n**Clinical Correlation**\n\nPatients with PRES present with headache, nausea, altered consciousness, visual disturbances, and seizures. The MRI typically shows symmetrical hyperintense lesions on T2/FLAIR sequences in the parieto-occipital lobes. The condition is reversible if promptly recognized and managed by controlling blood pressure and addressing the underlying cause.\n\n**Diagnostic Approach**\n\nDiagnosis of PRES is primarily clinical and radiologic. Differential diagnoses include acute ischemic stroke (which usually demonstrates diffusion restriction on MRI), encephalitis, and reversible cerebral vasoconstriction syndrome (RCVS). The bilateral and posterior distribution on MRI helps to distinguish PRES from other entities.\n\n**Management Principles**\n\nManagement focuses on rapid control of blood pressure using IV antihypertensive agents (e.g., nicardipine or labetalol) in a controlled fashion \u2013 typically targeting a 25% reduction in mean arterial pressure over the first few hours. Seizure control with anticonvulsants may be required. In pregnant patients (e.g., eclampsia), intravenous magnesium sulfate is indicated and BP management should be tailored to maternal and fetal risks; lactating mothers should be managed similarly with appropriate follow\u2010up.\n\n**Option Analysis**\n\nOption A (PRES) is correct. Although the option is noted as 'PRESS', it is understood to be a reference to Posterior Reversible Encephalopathy Syndrome. No other options were given, and the presentation aligns perfectly with this diagnosis.\n\n**Clinical Pearls**\n\n1. PRES is reversible with prompt management. 2. The typical MRI pattern is bilateral parieto-occipital vasogenic edema. 3. Severe hypertension is a key trigger.\n\n**Current Evidence**\n\nRecent guidelines emphasize careful blood pressure management and rapid identification of PRES. Neuroimaging (MRI) remains the cornerstone of diagnosis, and emerging literature continues to explore the various precipitating factors beyond hypertension, including drug toxicity and systemic inflammatory states.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 46,
    "question": "74-year-old male with CT brain image showing large hemorrhage in the cortex what to do next",
    "option_a": "MRI",
    "option_b": "CTA",
    "option_c": "conventional angio",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn a 74\u2010year\u2010old male presenting with a cortical hemorrhage on CT, determining the cause of the hemorrhage is paramount. CT angiography (CTA) is the recommended next step, as it enables evaluation for underlying vascular abnormalities such as aneurysms, arteriovenous malformations (AVMs), or the presence of active bleeding (spot sign).\n\n**Pathophysiology**\n\nIntracerebral hemorrhages result from the rupture of abnormal or diseased vessels. In elderly patients, lobar hemorrhages may also be related to cerebral amyloid angiopathy; however, when the hemorrhage is large and cortical, evaluation for other vascular abnormalities is warranted. CTA can rapidly detect vascular anomalies that might have contributed to the bleed.\n\n**Clinical Correlation**\n\nThe patient\u2019s clinical presentation along with the CT finding of a cortical hemorrhage suggests the need for urgent vascular imaging. CTA not only assists in identifying potential causes but also guides further management decisions (e.g., surgical intervention or conservative treatment).\n\n**Diagnostic Approach**\n\nFollowing a non-contrast CT that identifies hemorrhage, the differential includes hypertensive hemorrhage, amyloid angiopathy, vascular malformations, and aneurysmal rupture. CTA helps differentiate these entities by visualizing the vascular structure. MRI can be useful later for parenchymal details, while conventional angiography is typically reserved for cases where CTA is non-diagnostic or for therapeutic intervention planning.\n\n**Management Principles**\n\nImmediate management involves stabilization of the patient, blood pressure control, and reversal of anticoagulation if indicated. Guidelines suggest that CTA should be performed promptly to delineate the vascular anatomy and identify potential bleeding sources. In pregnant patients or lactating mothers, the risks and benefits of contrast exposure should be considered, but in life-threatening hemorrhage, maternal stabilization is prioritized.\n\n**Option Analysis**\n\nOption B (CTA) is correct because it provides a rapid, non-invasive method to evaluate the vascular anatomy in the setting of intracerebral hemorrhage. Option A (MRI) is less ideal in an acute hemorrhagic setting due to time constraints, while conventional angiography (Option C) is invasive and generally reserved for cases when non-invasive imaging is inconclusive or if endovascular therapy is contemplated.\n\n**Clinical Pearls**\n\n1. CTA is critical in the acute evaluation of intracerebral hemorrhage to identify potential vascular abnormalities. 2. Lobar hemorrhages in the elderly warrant careful investigation for amyloid angiopathy and other vascular lesions. 3. Time is brain - rapid imaging guides management.\n\n**Current Evidence**\n\nCurrent stroke guidelines support the use of CTA following detection of intracerebral hemorrhage on CT to detect a bleeding source or vascular anomaly. It is now a standard component in the acute stroke imaging protocol, with recent studies validating its role in predicting hematoma expansion via the 'spot sign'.",
    "exam_year": "2019",
    "exam_type": "Part I",
    "image_url": "page_12.png"
  },
  {
    "id": 47,
    "question": "Patient with small left internal capsule infarction and right-sided weakness for 2 days found to have PFO (not mentioned if there was a specific feature of it) HTN with uncontrolled BP. What is the treatment?",
    "option_a": "Aspirin",
    "option_b": "Warfarin",
    "option_c": "PFO closure",
    "option_d": "Aspirin and plavix",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis patient presents with a small left internal capsule infarction and right-sided weakness. Although a patent foramen ovale (PFO) is detected, the clinical context (lacunar infarct with uncontrolled hypertension) strongly favors a small vessel (lacunar) infarct due to hypertensive arteriopathy rather than an embolic event from a paradoxical embolism through the PFO.\n\n**Pathophysiology**\n\nLacunar infarcts occur due to occlusion of small penetrating arteries, typically as a consequence of chronic hypertension leading to arteriolosclerosis. While PFO can be a conduit for paradoxical emboli, its prevalence in the general population and the presence of significant vascular risk factors (like uncontrolled high blood pressure) point to a hypertensive etiology. Recent research emphasizes proper patient selection for PFO closure, typically in young patients with cryptogenic stroke.\n\n**Clinical Correlation**\n\nThe location of the infarct (internal capsule) and the clinical picture of pure motor stroke are classic for a lacunar event. In this context, the incidental finding of a PFO is unlikely to be the culprit. The focus should be on antiplatelet therapy and rigorous blood pressure control to prevent further lacunar events.\n\n**Diagnostic Approach**\n\nDiagnosis of a lacunar stroke is made based on clinical features and supported by imaging (often CT or MRI showing a small deep infarct). Differential diagnoses include embolic strokes (which typically involve cortical areas) and large artery atherosclerosis. A detailed cardiac evaluation and sometimes transesophageal echocardiography can be performed to assess the significance of a PFO, but only in selected cases of cryptogenic stroke in younger patients.\n\n**Management Principles**\n\nFirst-line management for lacunar stroke involves antiplatelet therapy, with aspirin being the standard agent. Concurrently, aggressive management of hypertension is required to reduce recurrence risk. Dual antiplatelet therapy (aspirin plus clopidogrel) is generally not indicated beyond the acute period except in specific scenarios. PFO closure is reserved for younger patients (<60 years) with cryptogenic stroke and high-risk PFO characteristics. In pregnancy and lactation, low-dose aspirin is often considered safe under guidance, but blood pressure management remains the priority.\n\n**Option Analysis**\n\nOption A (Aspirin) is correct. Warfarin (Option B) is not indicated in lacunar strokes without a cardioembolic source, and PFO closure (Option C) is generally not recommended in older patients with a clear alternative stroke mechanism. Option D (aspirin and clopidogrel) is not part of standard long-term management for lacunar strokes in this scenario.\n\n**Clinical Pearls**\n\n1. Lacunar strokes are typically due to small vessel disease related to uncontrolled hypertension. 2. An incidental PFO in an elderly patient with classic lacunar findings is not an indication for closure. 3. Strict control of blood pressure is critical to preventing recurrent lacunar strokes.\n\n**Current Evidence**\n\nRecent trials and meta-analyses underscore that PFO closure benefits are confined to younger patients with cryptogenic stroke and high-risk anatomical features. The current approach in older patients or those with clear alternative etiologies (like hypertension-induced small vessel disease) remains antiplatelet therapy and risk factor modification.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 48,
    "question": "Alexia without agraphia with hemianopia",
    "option_a": "PCA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAlexia without agraphia, often termed 'pure alexia,' is a disconnection syndrome where a patient loses the ability to read but retains the ability to write. This syndrome is most commonly associated with infarction in the territory of the posterior cerebral artery (PCA), particularly affecting the left occipital lobe and the splenium of the corpus callosum.\n\n**Pathophysiology**\n\nThe left occipital lobe is responsible for processing visual input, and the splenium of the corpus callosum connects the visual cortex to language areas in the dominant hemisphere. When both are compromised\u2014commonly due to an occlusion of the left PCA\u2014the patient can still write (as language production centers are intact) but cannot comprehend written words because visual input is not adequately relayed to these centers.\n\n**Clinical Correlation**\n\nPatients present with homonymous hemianopia (usually right-sided if the left PCA is involved) and a striking disassociation: the ability to write remains preserved while reading is impaired. This clinical presentation is pathognomonic for alexia without agraphia.\n\n**Diagnostic Approach**\n\nImaging, particularly MRI, will reveal infarction in the left occipital lobe and may show involvement of the splenium. Differential diagnoses include other forms of aphasia; however, the preservation of writing ability distinguishes alexia without agraphia. Additional evaluations, such as formal neuropsychological testing and visual field assessments, aid in confirmation.\n\n**Management Principles**\n\nAcute management of PCA stroke is similar to other ischemic strokes, where the focus is on reperfusion strategies (if within the thrombolytic window), antiplatelet therapy, and supportive care. Long-term management includes risk factor modification. In pregnant or lactating patients, thrombolytic therapy is considered only after careful risk\u2013benefit analysis and usually in specialized centers; antiplatelet therapies such as low-dose aspirin are generally considered safe under medical supervision.\n\n**Option Analysis**\n\nOption A (PCA) is correct as the syndrome is a classic presentation of a stroke in the distribution of the posterior cerebral artery, particularly affecting the left side. The other options, if presented, would not align with the vascular territory involved in this specific disconnection syndrome.\n\n**Clinical Pearls**\n\n1. Alexia without agraphia is a classic disconnection syndrome resulting from left occipital and splenium involvement. 2. A key feature is the loss of reading ability in the presence of preserved writing skills. 3. It is most commonly associated with infarction of the PCA territory.\n\n**Current Evidence**\n\nRecent stroke management guidelines continue to emphasize the importance of rapid diagnosis and reperfusion in acute ischemic strokes, including PCA infarcts. Advances in neuroimaging have improved the accuracy of localizing the infarct and predicting outcomes in disconnection syndromes such as alexia without agraphia.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 49,
    "question": "Patient with ataxia and vomiting CT attached (showing hypodensity at the whole right cerebellum at the level of the midbrain)",
    "option_a": "SCA",
    "option_b": "PCA",
    "option_c": "PICA",
    "option_d": "AICA",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis question evaluates the understanding of cerebellar vascular territories and their infarction patterns. The cerebellum is supplied by three major arteries: the Superior Cerebellar Artery (SCA), Anterior Inferior Cerebellar Artery (AICA), and Posterior Inferior Cerebellar Artery (PICA). A lesion seen at the level of the midbrain in the cerebellum is most consistent with the SCA territory.\n\n**Pathophysiology**\n\nAn infarction in the SCA territory occurs when there is occlusion, typically due to thromboembolism or local atherosclerotic disease, leading to ischemia of the superior aspect of the cerebellum. This ischemia disrupts cerebellar circuits responsible for coordination, resulting in ataxia, and can also affect vestibular integration, contributing to symptoms like vomiting.\n\n**Clinical Correlation**\n\nClinically, a patient with an SCA infarct usually presents with acute cerebellar symptoms such as ataxia, imbalance, and vomiting. CT imaging will demonstrate hypodensity within the affected cerebellar region. The midbrain level slice implicates the superior portion of the cerebellum, which is supplied by the SCA.\n\n**Diagnostic Approach**\n\nThe diagnosis is initially established using non-contrast CT to identify hypodense areas indicating ischemia. MRI (especially diffusion-weighted imaging) is more sensitive in the acute setting. Differential diagnoses include hemorrhagic stroke, cerebellar tumors, demyelinating lesions, and infarctions in other cerebellar territories (PICA or AICA infarcts), which are distinguished by their specific vascular distribution and imaging characteristics.\n\n**Management Principles**\n\nManagement begins with acute stroke protocols including IV thrombolysis if within the time window, supportive care, and monitoring for complications like edema and hydrocephalus. In selected cases, neurosurgical decompression may be indicated. In pregnant patients, the risk\u2010benefit assessment for thrombolytics is critical, with a preference for imaging modalities and treatments that minimize fetal radiation exposure. For lactating mothers, treatment adjustments may be needed to avoid transmission of potentially teratogenic agents.\n\n**Option Analysis**\n\nOption A (SCA) is correct because the CT at the level of the midbrain with whole cerebellar involvement on the right side fits the SCA infarction pattern. Option B (PCA) is incorrect because the PCA supplies the occipital lobe. Option C (PICA) typically affects the inferior cerebellum, and Option D (AICA) supplies the anterior inferior portion of the cerebellum, neither matching the described imaging level.\n\n**Clinical Pearls**\n\n1. In cerebellar strokes, early identification is key due to the risk of brainstem compression and hydrocephalus. 2. A CT slice at the midbrain level that shows cerebellar hypodensity is most suggestive of an SCA infarct. 3. Vomiting and ataxia without significant long tract signs point toward a localized cerebellar event.\n\n**Current Evidence**\n\nRecent guidelines emphasize early neuroimaging and prompt thrombolytic therapy, if appropriate, for ischemic stroke. Advances in MRI techniques help differentiate among cerebellar infarctions and assess for mass effect. Research continues to refine the management of posterior circulation strokes, particularly regarding surgical interventions in cases of cerebellar edema.",
    "exam_year": "2019",
    "exam_type": "Part I"
  },
  {
    "id": 50,
    "question": "Lady with 2 abortions came with stroke what to order",
    "option_a": "protein c def",
    "option_b": "Antithrombin 3",
    "option_c": "Antiphospholipid syndrome",
    "option_d": "Protein glycoprotein 20220",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis question centers on the evaluation of hypercoagulable states leading to both thrombotic events (such as stroke) and recurrent pregnancy loss. Antiphospholipid syndrome (APS) is a prime example where autoimmune antibodies create a proclivity for thrombosis, manifesting in both obstetric and vascular complications.\n\n**Pathophysiology**\n\nIn APS, autoantibodies (including lupus anticoagulant, anticardiolipin, and anti-\u03b22 glycoprotein I) interact with phospholipids and coagulation factors, leading to endothelial dysfunction and a hypercoagulable state. This results in thrombosis in both arteries and veins, as well as placental thrombosis, which can cause recurrent miscarriages.\n\n**Clinical Correlation**\n\nA young woman with a history of two abortions who now presents with a stroke fits the clinical picture of APS. The dual presentation of recurrent pregnancy loss and arterial thrombosis is highly suggestive of this syndrome, prompting evaluation with antiphospholipid antibody testing.\n\n**Diagnostic Approach**\n\nThe diagnostic workup includes testing for lupus anticoagulant, anticardiolipin antibodies, and anti-\u03b22 glycoprotein I antibodies, with repeat testing 12 weeks apart to confirm persistent positivity. Differential diagnoses include other thrombophilias such as Protein C deficiency, Protein S deficiency, and Factor V Leiden mutation; however, these rarely present with recurrent abortions to the degree seen in APS.\n\n**Management Principles**\n\nManagement of APS involves long-term anticoagulation. For a patient with a stroke, warfarin with a goal INR of 2.5-3.0 is often used; however, in women of childbearing age, especially during pregnancy, warfarin is contraindicated. In pregnancy, low molecular weight heparin in combination with low-dose aspirin is recommended to reduce both thrombotic and obstetric complications. Breastfeeding mothers are generally safely managed with heparin therapy.\n\n**Option Analysis**\n\nOption A (Protein C deficiency) and Option B (Antithrombin 3 deficiency) are inherited thrombophilias that can cause thrombosis but are less commonly associated with recurrent miscarriages. Option D (Protein glycoprotein 20220 mutation) is associated with thrombosis but again, the combination of stroke and recurrent abortions is most suggestive of APS, making Option C the correct choice.\n\n**Clinical Pearls**\n\n1. Recurrent pregnancy loss combined with thrombotic events is a classic presentation of APS. 2. Confirmatory testing for APS requires demonstration of persistent positivity for antiphospholipid antibodies on two occasions, at least 12 weeks apart. 3. Management strategies differ drastically during pregnancy, with a shift toward heparin-based therapies.\n\n**Current Evidence**\n\nRecent guidelines from the American College of Rheumatology and hematology recommend aggressive anticoagulation in APS patients with thrombotic events. There is increasing evidence to support the combination of low-molecular-weight heparin and low-dose aspirin in pregnant patients to reduce both thrombotic risk and miscarriage rates. Additionally, DOACs are being evaluated but have not yet supplanted warfarin or heparin in high-risk APS, especially in a pregnant population.",
    "exam_year": "2019",
    "exam_type": "Part I"
  }
]